tailieunhanh - Báo cáo y học: "Predicting the future of anti-tumor necrosis factor therapy"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Predicting the future of anti-tumor necrosis factor therapy. | Available online http content 11 3 115 Editorial Predicting the future of anti-tumor necrosis factor therapy Cornelis L Verweij Division of Inflammatory Disease Profiling Department of Pathology and Rheumatology VU University Medical Center . Box 7057 1007MB Amsterdam The Netherlands Corresponding author Cornelis L Verweij Published 22 June 2009 Arthritis Research Therapy 2009 11 115 doi ar2724 This article is online at http content 11 3 115 2009 BioMed Central Ltd See related research by Hueber et al. http content 11 3 R76 Abstract Tumor necrosis factor TNF antagonists are approved worldwide for the treatment of rheumatoid arthritis RA . Clinical experience revealed that TNF-blocking therapy is effective for only approximately two thirds of patients reflecting that there are responders as well as nonresponders . Given the destructive nature of RA the risk of adverse effects and considerable costs for therapy there is a strong need to make predictions on success before the start of therapy. In the current issue of Arthritis Research Therapy Hueber and colleagues become the first to present a multiparameter serum protein biomarker set that has predictive value prior to the start of anti-TNF treatment. Ultimately this finding may contribute to a personalized form of medicine whereby a specific therapy will be applied that is best suited to an individual patient. The concept of a personalized form of medicine has attracted interest in the search for molecular and clinical criteria to dissect anti-tumor necrosis factor TNF responders from non-responders in rheumatoid arthritis RA . Essentially two phases of unresponsiveness might be identified a primary phase directly after the start of treatment and a secondary phase that develops in initial responders during the course of therapy. The latter is explained by the formation of anti-drug antibodies anti-anti-TNF antibodies .

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.